(3S)-3-[[芴甲氧羰基]氨基]-4-甲基戊酸 | 266318-79-0
中文名称:
(3S)-3-[[芴甲氧羰基]氨基]-4-甲基戊酸
英文名称:
(3S)-3-({(9H-fluoren-9-yl)methoxycarbonyl}amino)-4-methylpentanoic acid
CAS No.:
266318-79-0
分子式:
C2 1 H2 3 NO4
分子量:
353.41200
名称和标识符
MDL
MFCD03095625
InChIKey
KFDMTAMWOIQTOB-IBGZPJMESA-N
Inchi
InChI=1S/C21H23NO4/c1-13(2)19(11-20(23)24)22-21(25)26-12-18-16-9-5-3-7-14(16)15-8-4-6-10-17(15)18/h3-10,13,18-19H,11-12H2,1-2H3,(H,22,25)(H,23,24)/t19-/m0/s1
SMILES
CC([C@@H](NC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)CC(O)=O)C
别名信息
- 中文别名 -
N-Fmoc-(S)-3-氨基-4-甲基戊酸
(3S)-3-[[芴甲氧羰基]氨基]-4-甲基戊酸
- 英文别名 -
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanoic acid
Fmoc-D-beta-homovaline
Fmoc-D-β-HomoVal-OH
N-Fmoc-α-isopropyl-β-alanine
Pentanoic acid,3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4-methyl-, (3S)-
Fmoc-L-beta-homovaline
Fmoc-D-β-Homo-Val
FMOC-D--LEU-OH
(3S)-3-({(9H-fluoren-9-yl)methoxycarbonyl}amino)-4-methylpentanoic acid
物化性质
实验特性
LogP
4.41530
PSA
75.63000
沸点
563.9±33.0℃ at 760 mmHg
溶解度
Insuluble (6.4E-3 g/L) (25 ºC),
密度
1.207±0.06 g/cm3 (20 ºC 760 Torr),
计算特性
精确分子量
353.16300
氢键供体数量
2
氢键受体数量
5
可旋转化学键数量
8
重原子数量
26
相关文献
1.
Modular design for the controlled production of polymeric nanotubes from polymer/peptide conjugates
Robert Chapman,Katrina A. Jolliffe,Sébastien Perrier Polym. Chem. 2011 2 1956
2.
Blocking the heat shock response and depleting HSF-1 levels through heat shock protein 90 (hsp90) inhibition: a significant advance on current hsp90 chemotherapies
Yen Chin Koay,Jeanette R. McConnell,Yao Wang,Shelli R. McAlpine RSC Adv. 2015 5 59003
3.
Fluorinated nanotubes: synthesis and self-assembly of cyclic peptide–poly(vinylidene fluoride) conjugates
Enrique Folgado,Qiao Song,Sebastien Perrier,Vincent Ladmiral,Mona Semsarilar Polym. Chem. 2021 12 4235
4.
Design and synthesis of 3,3′-biscoumarin-based c-Met inhibitors
Jimin Xu,Jing Ai,Sheng Liu,Xia Peng,Linqian Yu,Meiyu Geng,Fajun Nan Org. Biomol. Chem. 2014 12 3721
5.
On the inhibition of capsaicin response in dorsal root ganglion neurons by nobilamide B and analogues: a structure–activity relationship study
Oliver John V. Belleza,Jortan O. Tun,Gisela P. Concepcion,Aaron Joseph L. Villaraza Med. Chem. Commun. 2018 9 1673
6.
Efficient synthesis of novel conjugated 1,3,4-oxadiazole–peptides
Farhad Golmohammadi,Saeed Balalaie,Fatima Hamdan,Shokoofeh Maghari New J. Chem. 2018 42 4344
7.
Piperazic acid-containing natural products: Isolation, biological relevance and total synthesis
Alexander J. Oelke,David J. France,Tatjana Hofmann,Georg Wuitschik,Steven V. Ley Nat. Prod. Rep. 2011 28 1445
8.
Piperazic acid-containing natural products: Isolation, biological relevance and total synthesis
Alexander J. Oelke,David J. France,Tatjana Hofmann,Georg Wuitschik,Steven V. Ley Nat. Prod. Rep. 2011 28 1445
9.
Co-delivery of proapoptotic peptide and p53 DNA by reduction-sensitive polypeptides for cancer therapy
Si Chen,Lei Rong,Hui-Zhen Jia,Si-Yong Qin,Xuan Zeng,Ren-Xi Zhuo,Xian-Zheng Zhang Biomater. Sci. 2015 3 753
10.
A self-delivery system based on an amphiphilic proapoptotic peptide for tumor targeting therapy
Si Chen,Jin-Xuan Fan,Xin-Hua Liu,Ming-Kang Zhang,Fan Liu,Xuan Zeng,Guo-Ping Yan,Xian-Zheng Zhang J. Mater. Chem. B 2019 7 778